Search research articles
Contact Us
Filters
Showing results (321-330 of 392) with videos related to
Page
of 40
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 5, 2023
Locus Coeruleus Integrity Is Linked to Response Inhibition Deficits in Parkinson's Disease and Progressive Supranuclear Palsy
Rong Ye, Frank H Hezemans, Claire O'Callaghan, et al.
Brain : a Journal of Neurology
|
June 26, 2016
Atomoxetine restores the response inhibition network in Parkinson's disease
Charlotte L Rae, Cristina Nombela, Patricia Vázquez Rodríguez, et al.
Molecular Genetics and Metabolism
|
April 5, 2026
Cerebrospinal fluid heparan sulfate as a biomarker for neuronopathic mucopolysaccharidoses: Rationale and regulatory challenges
Joseph Muenzer, Mark Dant, Patricia I Dickson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 16, 2017
[<sup>18</sup>F]AV-1451 binding in vivo mirrors the expected distribution of TDP-43 pathology in the semantic variant of primary progressive aphasia
W R Bevan-Jones, Thomas E Cope, P Simon Jones, et al.
Molecular Genetics and Metabolism
|
March 5, 2013
The Morquio A Clinical Assessment Program: baseline results illustrating progressive, multisystemic clinical impairments in Morquio A subjects
Paul Harmatz, Karl Eugen Mengel, Roberto Giugliani, et al.
Hepatology (Baltimore, Md.)
|
January 26, 2013
Clinical effect and safety profile of recombinant human lysosomal acid lipase in patients with cholesteryl ester storage disease
Manisha Balwani, Catherine Breen, Gregory M Enns, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 12, 2020
Synaptic Loss in Primary Tauopathies Revealed by [<sup>11</sup> C]UCB-J Positron Emission Tomography
Negin Holland, P Simon Jones, George Savulich, et al.
Neurobiology of Aging
|
February 25, 2021
Imaging tau burden in dementia with Lewy bodies using [<sup>18</sup>F]-AV1451 positron emission tomography
Elijah Mak, Nicolas Nicastro, Maura Malpetti, et al.
Neurobiology of Aging
|
March 5, 2019
Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia
Timothy Rittman, Robin Borchert, Simon Jones, et al.
Plos Computational Biology
|
May 9, 2022
Noradrenergic deficits contribute to apathy in Parkinson's disease through the precision of expected outcomes
Frank H Hezemans, Noham Wolpe, Claire O'Callaghan, et al.
Page
of 40
Search research articles
Search
Showing results (321-330 of 392) with videos related to
Sort By:
Page
of 40
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 5, 2023
Locus Coeruleus Integrity Is Linked to Response Inhibition Deficits in Parkinson's Disease and Progressive Supranuclear Palsy
Rong Ye, Frank H Hezemans, Claire O'Callaghan, et al.
Brain : a Journal of Neurology
|
June 26, 2016
Atomoxetine restores the response inhibition network in Parkinson's disease
Charlotte L Rae, Cristina Nombela, Patricia Vázquez Rodríguez, et al.
Molecular Genetics and Metabolism
|
April 5, 2026
Cerebrospinal fluid heparan sulfate as a biomarker for neuronopathic mucopolysaccharidoses: Rationale and regulatory challenges
Joseph Muenzer, Mark Dant, Patricia I Dickson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 16, 2017
[<sup>18</sup>F]AV-1451 binding in vivo mirrors the expected distribution of TDP-43 pathology in the semantic variant of primary progressive aphasia
W R Bevan-Jones, Thomas E Cope, P Simon Jones, et al.
Molecular Genetics and Metabolism
|
March 5, 2013
The Morquio A Clinical Assessment Program: baseline results illustrating progressive, multisystemic clinical impairments in Morquio A subjects
Paul Harmatz, Karl Eugen Mengel, Roberto Giugliani, et al.
Hepatology (Baltimore, Md.)
|
January 26, 2013
Clinical effect and safety profile of recombinant human lysosomal acid lipase in patients with cholesteryl ester storage disease
Manisha Balwani, Catherine Breen, Gregory M Enns, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 12, 2020
Synaptic Loss in Primary Tauopathies Revealed by [<sup>11</sup> C]UCB-J Positron Emission Tomography
Negin Holland, P Simon Jones, George Savulich, et al.
Neurobiology of Aging
|
February 25, 2021
Imaging tau burden in dementia with Lewy bodies using [<sup>18</sup>F]-AV1451 positron emission tomography
Elijah Mak, Nicolas Nicastro, Maura Malpetti, et al.
Neurobiology of Aging
|
March 5, 2019
Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia
Timothy Rittman, Robin Borchert, Simon Jones, et al.
Plos Computational Biology
|
May 9, 2022
Noradrenergic deficits contribute to apathy in Parkinson's disease through the precision of expected outcomes
Frank H Hezemans, Noham Wolpe, Claire O'Callaghan, et al.
Page
of 40